전진바이오팜

110020KOSDAQ기타 화학제품 제조업

64.3 / 100

Reference Date: 2026-07-24

Financial Score18.0 / 40

News Sentiment21.3 / 25

Momentum15.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Surged 30.1% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Jeonjin Biofarm operates three business segments—household products, wildlife damage reduction solutions, and pet supplies—leveraging its R&D expertise in natural materials since its 2004 founding. Household products account for approximately 80% of revenue, while pet supplies grew to 14.19% in 2025. Key products include capsule detergents, air fresheners, and wildlife repellents, with notable price fluctuations observed in both domestic and export markets.

Number of Employees

57people

Average Salary

27.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 16.674.0Point

PBR

1.17Industry Average 1.062.5Point

Higher than industry avg (caution)

ROE

-1.12Industry Average 4.550.0Point

Well below industry avg

Debt Ratio

1.30Industry Average 8.138.0Point

Half of industry avg (excellent)

Trend 2023~20253.5 / 10 points

Revenue Growth Rate

0.5 / 3

Avg ▼3.0% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲31.7% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -15.4% (improving, 3yr)

Detailed News Sentiment

2 totalPositive 2Neutral 0Negative 0Average Sentiment Score 85

Positive
전진바이오팜, 홈케어 사업 포트폴리오 확대
전진바이오팜이 홈케어 사업 확장을 위해 신제품 공급 확대로 포트폴리오를 다각화함으로써 긍정적인 시장 반응을 기대.
Positive
전진바이오팜 "홈케어 신제품 공급 확대…글로벌 시장 공략"
전진바이오팜이 글로벌 유통기업과의 신규 홈케어 제품 공급 확대로 글로벌 시장 진출을 확대하며 긍정적인 성장 전망을 보임.

Detailed Momentum

52-week position3.0Point

52w lower range (25%)

Current 2,250Won52-week high 4,00052-week low 1,641

1-month return6.0Point

1m +30.06% (strong rise)

Volume trend6.0Point

Volume surge

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0